ArticleJAMIA open2026
Patterns and predictors of clinician use of interoperability tools.
Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Clinicians' adoption of interoperability tools influences care quality, but evidence of actual use is limited. We analyze clinicians' use of outside records delivered via Epic Care Everywhere (CE), focusing on use frequency and predictors such as gender, experience, specialty, and role. Differences between pre-pandemic (2018-2019) and pandemic (2020-2021) periods are also examined to see how COVID-19 affected use of outside records. Materials and methods: De-identified EHR metadata from UCSF clinicians ( Results: CE usage intensity rose by 43.0% post-COVID-19 onset compared with the pre-pandemic. Clinician specialty most strongly predicted use, with Nephrology and Cardiology showing the highest breadth (56.0% and 53.0% of visits, respectively), while Dermatology (13.2%) and Pediatrics (23.4%) were lowest. Residents used CE at 23.0% greater intensity than attendings, and each additional year of experience was linked to a 0.57% decrease in intensity. Discussion: Clinician use of interoperability tools was higher in specialties such as Nephrology and Cardiology that require more care coordination, and among less experienced clinicians including resident physicians. Use increased after the pandemic began, likely due to ongoing adoption trends and increased clinical demands during system strain and uncertainty. Conclusion: These findings underscore the critical importance of considering clinician behavior and contextual factors, such as specialty care needs, in addition to technical capabilities, when promoting the adoption and use of interoperability tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.